The Prescriptions of Antipsychotic Polypharmacy and Antiparkinson Drugs have been Changed in Psychiatric Practice

實務中併用抗精神病藥物與處方抗巴金森藥物的趨勢已有改變

黃斯聖(Si-Sheng Huang)

台灣精神醫學

27卷4期（2013 / 12 / 01）

263 - 266

英文

1. Wu, YH,Huang, MF,Lai, CY(2013).Changing patterns of antipsychotic prescription and concomitant antiparkinson drug use at a Taiwanese psychiatric hospital.Taiwanese Journal of Psychiatry,27,306-17.
   連結：
2. Arilla, JA,Fernandez, ME,Vinuales, E(2010).Antipsychotic polypharmacy in a general hospital inpatient psychiatric unit.Rev Psiquiatr Salud Ment,3,90-6.
3. Chong, MY,Tan, CH,Fujii, S(2004).Antipsychotic drug prescription for schizophrenia in east Asia: rationale for change.Psychiatry Clin Neurosci,58,61-7.
4. Constantine, RJ,Andel, R,Tandon, R(2010).Trends in adult antipsychotic polypharmacy: progress and challenges in Florida's Medicaid program.Community Ment Health J,46,523-30.
5. Constantine, RJ,Boaz, T,Tandon, R(2010).Antipsychotic polypharmacy in the treatment of children and adolescents in the fee-for-service component of a large state Medicaid program.Clin Ther,32,949-59.
6. Correll, CU(2008).Antipsychotic polypharmacy, Part 2: why use 2 antipsychotics when 1 is not good enough?.J Clin Psychiatry,69,860-1.
7. Correll, CU,Rummel-Kluge, C,Corves, C,Kane, JM,Leucht, S(2009).Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials.Schizophr Bull,35,443-57.
8. Correll, CU,Shaikh, L,Gallego, JA(2011).Antipsychotic polypharmacy: a survey study of prescriber attitudes, knowledge and behavior.Schizophr Res,131,58-62.
9. Florez, Menéndez G,Blanco, Ramos M,Gómez-Reino, Rodriguez I(2004).Polypharmacy in the antipsychotic prescribing in practices psychiatric outpatient clinic.Actas Esp Psiquiatr,32,333-9.
10. Gallego, JA,Bonetti, J,Zhang, J(2012).Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009.Schizophr Res,138,18-28.
11. Goodwin, G,Fleischhacker, W,Arango, C(2009).Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.Eur Neuropsychopharmacol,19,520-32.
12. Huang, SS,Liao, YC,Hsieh, YY(2006).Combination antipsychotic therapy in psychiatric outpatient clinics in Taiwan.Compr Psychiatry,47,421-5.
13. Kishimoto, T,Watanabe, K,Uchida, H(2013).Antipsychotic polypharmacy: a Japanese survey of prescribers' attitudes and rationales.Psychiatry Res,209,406-11.
14. Misawa, F,Shimizu, K,Fujii, Y(2011).Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects?: a crosssectional study.BMC Psychiatry,11,118.
15. Santone, G,Bellantuono, C,Rucci, P(2011).Patient characteristics and process factors associated with antipsychotic polypharmacy in a nationwide sample of psychiatric inpatients in Italy.Pharmacoepidemiol Drug Saf,20,441-9.
16. Sim, K,Su, A,Fujii, S(2004).Antipsychotic polypharmacy in patients with schizophrenia: a multicentre comparative study in East Asia.Br J Clin Pharmacol,58,178-83.
17. Tognoni, G(1999).Pharmacoepidemiology of psychotropic drugs in patients with severe mental disorders in Italy: Italian collaborative study group on the outcome of severe mental disorders.Eur J Clin Pharmacol,55,685-90.
18. Tsutsumi, C,Uchida, H,Suzuki, T(2011).The evolution of antipsychotic switch and polypharmacy in natural practice-a longitudinal perspective.Schizophr Res,130,40-6.
19. Xiang, YT,Dickerson, F,Kreyenbuhl, J(2012).Common use of antipsychotic polypharmacy in older Asian patients with schizophrenia (2001-2009).J Clin Psychopharmacol,32,809-13.

1. 鄭淑文,詹宏裕(2017).Antipsychotic Prescription Pattern among Child and Adolescent Patients with Psychiatric Illnesses in Taiwan.臺灣精神醫學,31(3),222-231+iv.